JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.

Home
Signaling Pathways

Signaling Pathways

B4981 Sumatriptan

Target: 5-HT1 Receptors

Summary: 5-HT1 receptor agonist

≥14.77 mg/mL
B2235 Clozapine

Target: 5-HT2 Receptors|D1 and D5 Receptors|D2 Receptors|D3 Receptors|5-HT1 Receptors|D4 Receptors

Summary: 5-HT receptor antagonist

insoluble in H2O; ≥14.95 mg/mL
B2232 Aripiprazole

Target: 5-HT1 Receptors

Summary: 5-HT receptor partial agonist

≥22.4 mg/mL
B1477 Lurasidone HCl

Target: 5-HT2 Receptors|D2 Receptors|5-HT1 Receptors|5-HT7 Receptors

Summary: Dopamine D2/5-HT2A/5-HT7/5-HT1A inhibitor

insoluble in H2O; insoluble in EtOH; ≥11.11 mg/mL
A5294 Sumatriptan Succinate

Target: 5-HT1 Receptors

Summary: 5-HT1 receptor agonist

insoluble in EtOH; ≥136.8 mg/mL
B6337 8-Hydroxy-DPAT hydrobromide

Target: 5-HT1 Receptors

Summary: 5-HT1A agonist

≥52 mg/mL
A8496 Paliperidone

Target: 5-HT2 Receptors|D2 Receptors|D3 Receptors|5-HT1 Receptors|Histamine H1 Receptors

Summary: Dopamine receptor antagonist

insoluble in H2O; insoluble in EtOH; ≥10.662 mg/mL
A3926 Vortioxetine

Target: 5-HT1 Receptors|5-HT7 Receptors|5-HT3 Receptors|SERT

Summary: 5-HT receptors antagonist

insoluble in H2O; ≥14.92 mg/mL